Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History and Disease Burden of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED): An Observational, Multicentre, International Study (EdeReaLife)

NCT07096206 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT07096206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07096206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History and Disease Burden of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED): An Observational, Multicentre, International Study (EdeReaLife)
Lead sponsor
Pierre Fabre Medicament
Phase
Observational
Overall status
Completed
Start date
July 19, 2023
Completion date
November 26, 2025
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked hypohidrotic ectodermal dysplasia (xlhed)